Commodity Channel Index
|Bid||42.49 x 1000|
|Ask||42.57 x 800|
|Day's Range||41.68 - 43.33|
|52 Week Range||28.19 - 51.48|
|Beta (5Y Monthly)||0.69|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 05, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||54.17|
WARSAW, Ind., June 22, 2020 -- OrthoPediatrics Corp. (“OrthoPediatrics”) (Nasdaq: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics,.
OrthoPediatrics Corp. (“OrthoPediatrics”) (KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today the pricing of its underwritten public offering of 1,600,000 shares of its common stock at a price to the public of $47.00 per share. In addition, OrthoPediatrics has granted the underwriters a 30-day option to purchase up to an additional 240,000 shares of its common stock at the public offering price, less the underwriting discounts and commissions. Piper Sandler and Stifel are acting as joint book-running managers and BTIG, JMP Securities, Needham & Company, and SunTrust Robinson Humphrey are acting as co-managers of the proposed offering.
OrthoPediatrics Corp. (“OrthoPediatrics”) (KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today that it is commencing an underwritten public offering of its common stock. OrthoPediatrics intends to grant the underwriters a 30-day option to purchase additional shares of its common stock at the public offering price, less the underwriting discounts and commissions. OrthoPediatrics intends to use the net proceeds from the proposed offering to invest in implant and instrument sets for consignment to its customers, fund research and development activities, and expand its sales and marketing programs, and for working capital and general corporate purposes.
In this article we will take a look at whether hedge funds think OrthoPediatrics Corp. (NASDAQ:KIDS) is a good investment right now. We check hedge fund and billionaire investor sentiment before delving into hours of research. Hedge funds spend millions of dollars on Ivy League graduates, unconventional data sources, expert networks, and get tips from […]
OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, is pleased to announce the initial U.S. launch of the ApiFix Minimally Invasive Deformity Correction (“ApiFix”) system. Additionally, the Company anticipates approximately 20 leading clinical centers in the United States to enter data related to the use of the ApiFix system into a post-approval study registry hosted by the Pediatric Spine Study Group in order to continue monitoring the safety and probable benefit of the device for the treatment of progressive adolescent idiopathic scoliosis (“AIS”).
OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced the Company’s continued Double-Diamond sponsorship for the virtual 2020 Pediatric Orthopaedic Society of North America (“POSNA”) Annual Meeting, which will open online May 13, 2020 and remain available until December 31, 2020. OrthoPediatrics retains its designation as a Double Diamond Sponsor with additional sponsorship of specialty symposiums as well as support of educational grants. In addition to its ongoing commitments, the Company will also utilize a virtual display to highlight the PediFoot Deformity Correction (“PediFoot”) System, Next Generation Cannulated Screw Systems, and QuickPack™, all of which were recently introduced in the U.S. in the second half of 2019.
Ladies and gentlemen, thank you for standing by, and welcome to the Q1 2020 OrthoPediatrics Corp Earnings Conference Call. Joining me from the Company are Mark Throdahl, Chief Executive Officer; Fred Hite, Chief Financial Officer; and David Bailey, Executive Vice President.
OrthoPediatrics (KIDS) delivered earnings and revenue surprises of -11.11% and -3.52%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
WARSAW, Ind., May 05, 2020 -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on advancing the field of pediatric.
WARSAW, Ind., April 29, 2020 -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on advancing the field of pediatric.
OrthoPediatrics Corp. (“OrthoPediatrics”) (KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that the Company is scheduled to release its first quarter 2020 financial results on Tuesday, May 5, 2020, after the market closes. OrthoPediatrics will host a conference call on Wednesday, May 6, 2020, at 8:00 a.m. ET to discuss the results. The dial-in numbers are (855) 289-4603 for domestic callers and (614) 999-9389 for international callers.
OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, is pleased to announce that it has acquired ApiFix Ltd. (“ApiFix”), including its minimally invasive deformity correction (“MID-C”) system for non-fusion treatment of progressive adolescent idiopathic scoliosis (“AIS”), for 934,768 shares of OrthoPediatrics common stock and $2 million in cash paid at closing, plus milestone payments and an earnout over a period of four years. ApiFix Ltd. is an Israel and Boston, MA based medical device company with a less invasive spinal deformity correction system for non-fusion treatment of progressive AIS.
OrthoPediatrics Corp. (“OrthoPediatrics”) (KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration to expand the indications for its RESPONSE™ Scoliosis System to include neuromuscular implants. This 510(k) clearance represents a significant milestone in the Company’s development toward its next generation RESPONSE Scoliosis System, RESPONSE™ NeuroMuscular (“RESPONSE – NM”). This new system will be entirely dedicated to the treatment of neuromuscular scoliosis in pediatrics and builds on existing product offerings focused on treating this unique class of patients.
OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today provided a business update on the proactive steps it is taking in response to the global COVID-19 pandemic. As hospitals globally postpone elective procedures to generate capacity for treating COVID-19 patients, the Company is withdrawing its previously announced 2020 revenue guidance of growth in the range of 22%-24% and investment in consignment sets in a range of $19-$21 million.
WARSAW, Ind., March 09, 2020 -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric.
Consecutive year of record annual revenue with 26.0% year-over-year growth to $72.6 million Full year 2020 revenue growth guidance in the range of 22% to 24% WARSAW, Ind.,.
OrthoPediatrics Corp. (“OrthoPediatrics”) (KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, today announced an updated agreement with Medical 2011 S.r.l. Medical 2011 has served as OrthoPediatrics’ stocking distributor since 2013 and under the terms of the agreement, OrthoPediatrics will sell direct to hospitals in Italy with Medical 2011 as the Company’s exclusive sales agency.
OrthoPediatrics Corp. (“OrthoPediatrics”) (KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced it will attend the 6th Annual International Children’s Spine Symposium (ICSS), which will take place March 13-14, 2020 in Orlando, Florida. As such it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions.
OrthoPediatrics Corp. (KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce that it was recently named one of the Best Places to Work in Indiana by the Indiana Chamber of Commerce and Best Companies Group. OrthoPediatrics’ recognition and inclusion in the fifteenth annual program is the fourth time the Company has been honored with this award. This survey and awards program were designed to identify, recognize and honor the best employers in Indiana, benefiting the state’s economy, workforce and businesses.
You've probably seeing a bunch of stories lately about how the stock market rally has become too narrow. What's that mean? Simply put, a few mega-cap tech stocks are responsible for most of the market's gains lately. If you own the huge tech names, it's been great recently. But much of the market, and especially small stocks, has been left behind.Some investors have decided to stop fighting the wave. No price is too high for something like Apple (NASDAQ:AAPL), apparently, as long as the momentum keeps going. Even an earnings warning could hardly keep Apple down.At some point, though, the situation will flip. As a result, some investors are booking gains on their highly successful tech positions, and are rotating into other stocks that haven't had huge rallies yet.InvestorPlace - Stock Market News, Stock Advice & Trading TipsHistorically, small capitalization stocks have outperformed the broad market over the years. And after a disappointing 2019, they may be ready to punch above their weight in 2020. Consider that the new coronavirus from China is having a disproportionate impact on Chinese companies, and American multinationals with a large presence in Asia. Meanwhile, smaller American firms are much less sensitive to the problems. * 7 Failing Tech Stocks to Disconnect From Now As such, this could be a great time to move some money out of overpriced high-fliers and pick up some small stocks while they're still cheap. Global Water Resources (GWRS)Source: Shutterstock If you're thinking of exciting small-cap stocks, a utility probably wouldn't be your first choice. But don't be so quick to count out Global Water Resources (NASDAQ:GWRS). The $300 million market capitalization Arizona water utility is a fascinating company.Right now, it's fairly modest, as it serves only about 50,000 water taps. These are primarily in the Phoenix suburb of Maricopa. However, it, like Phoenix, is booming. Its customer base has nearly doubled since the Great Financial Crisis. Arizona is one of the fastest-growing states in the U.S., and Global Water Resources has focused its M&A activity on the fast-growing towns within the Phoenix metro area.More growth will be on the way. The Nikola Motor Company announced plans to build a 1 million square foot facility to manufacture hydrogen vehicles at a newly-established Arizona inland port. Global Water will be handling the water logistics. The federal government also just showered the new inland port with $39 million in subsidies. This ensures that Global Water's new project will obtain more paying utility customers quickly. It should lead to more new housing communities in its service area as well.People have been recommending homebuilder stocks as a way to play the recovery of housing and the rising trend of millenials finally buying homes. And that's a fine idea. But it's one that comes with significant risk if the economy goes south. Global Water, by contrast, gives access to one of the nation's hottest (literally and figuratively) housing markets without the downside risk if prices stall out again. People will keep using their water regardless of what the economy does, after all.As an added kicker, Global Water pays a monthly dividend of 2.4 cents per share, which amounts to 2.1% annually. They also tend to hike the dividend annually. So if you've been looking for another monthly-payer dividend stock for your portfolio, give Global Water a look. Catchmark Timber (CTT)One nice thing about small-cap stocks is that you can get exposure to different types of assets. Many of these fly under the radar. Like Arizona water utilities, such as we just discussed. Or how about a pure-player timber holding company, in the form of Catchmark Timber (NYSE:CTT)? Yes, there are other timber REITs that are publicly-traded, but they invest in manufacturing and processing their wood products.Catchmark, by contrast, only deals in owning timberlands directly. This makes the company a major inflation hedge, as you get pure commodity exposure to U.S. (primary southeastern) land holdings and, obviously, the price of timber going forward. While there will be plenty of bumps along the way for both, over time, like inflation, these should head solidly higher. * 7 Failing Tech Stocks to Disconnect From Now Why pick up Catchmark stock now? Shares have been relatively quiet for the last few years. This has left shares at a fair price now, with the timber player offering a 4.9% dividend yield. That's a healthy dose of income from a stock that also serves as a robust inflation hedge for your portfolio. New York Community Bancorp (NYCB)Source: Shutterstock If you like small stocks with big dividends, this next one packs an even bigger punch than Catchmark. New York Community Bancorp (NYSE:NYCB) offers a well-covered 6.1% dividend yield from its low-risk New York metro-area multi-family lending business. And, in fact, the bank just announced a fantastic quarter, and yet the share price actually dropped a few percent.For years, the bank has been dogged by critics. They've complained about the bank's falling profit margins, lack of growth, and a stale business model. That's all changed for the better in recent months. For one, the government eased federal banking regulations, allowing NYCB to grow beyond the old $50 billion asset cap. This, for the first time since the financial crisis, will let New York Community Bancorp expand its balance sheet normally again.On top of that, New York Community Bancorp has a sort of counter-cyclical loan book that didn't benefit from higher interest rates immediately. Now, however, while other banks are seeing their margins plummet with Fed rate cuts, NYCB's margins and EPS have just kicked into solidly positive territory. Even after delivering a fantastic quarter, critics have moved on to complaining about the bank's exposure to New York City apartments. Local government there just changed rent control laws, and this has had a negative effect on local prices.No matter though, NYCB lends less than 60% of the value of these properties so even a significant dip in housing prices won't cause the bank losses. NYCB was one of the safest banks in the country in the 2008 crisis, and experienced essentially zero lending losses even then. It's time to take advantage of the market's inappropriate reaction to NYCB's excellent earnings. The stock already yields 6.1%, and with earnings kicking into growth mode again, look for more share buybacks or a dividend hike in coming quarters. It also trades at just 13x earnings and is a buyout target as the CEO advances in age and may look for an exit strategy. The ONE Group Hospitality (STKS)Source: Shutterstock The ONE Group Hospitality (NASDAQ:STKS) is a small restaurant operator primarily known for its STK steakhouses. These are a high-end concept, with the 14 ounce Dry-Aged Delmonico going for $74 at its Walt Disney World location, to give one example. Despite that, remarkably enough, STK historically had struggled to generate high enough profit margins at its restaurants.However, things have turned around since new CEO Manny Hilario took over the reins at the end of 2017. STK has started reporting fantastic same store sales growth (high single digits) while at the same time bringing down overhead costs. The ONE Group's stock price has tripled under Hilario's watch.And now he'll get a shot at repeating his success. That's because The ONE Group just acquired 24 Kona Grill restaurant locations out of bankruptcy. That company had infamously free-spending leadership and a muddled menu and corporate identity in recent years. Remarkably, Kona Grill had a market capitalization of $300 million as recently as 2015. Now, The ONE Group grabbed the best two dozen Kona Grill locations for just $36 million. That's sizable discount to the cost of merely building the restaurants, let alone establishing the brand. * 7 Failing Tech Stocks to Disconnect From Now STKS stock is up from $1.50 to $4.50 in recent years under the new CEO's excellent leadership. If he can help resuscitate Kona Grill, who knows how much higher the stock could go. Rocky Mountain Chocolate Factory (RMCF)Source: JHVEPhoto / Shutterstock.com Given all the attention on edibles lately, you would be forgiven for assuming that a Colorado packaged foods company had something to do with the cannabis market. But, at least for now, Rocky Mountain Chocolate Factory (NASDAQ:RMCF) instead sells premium chocolates at more than 300 stores including many co-branded Cold Stone Creamery locations. It also has a frozen yogurt brand, U-Swirl.The company's chocolate is indeed premium, bringing in an average retail price of more than $23 per pound. If you're familiar with Warren Buffett's history, he often cites his investment in See's Candies as one of his finest investments. It's repaid its original purchase price many times over by now. That's because the economics of chocolate are simply fantastic. You get massive profit margins.Rocky Mountain Chocolate Factory shares in that bounty with shareholders, paying a 6% dividend yield. Alas, due to strategic missteps, such as errors with the yogurt brand, the company's profits and share price have struggled in recent years. However, an activist has come in to shake the company up and new people have joined the board. Further to that point, the company has just launched a major partnership with Edible Arrangements to sell its chocolates at more than 1,000 Edible Arrangements stores. This should boost utilization at Rocky Mountain's Colorado factory and get profits on the upswing again. OrthoPediatrics (KIDS)Source: Shutterstock This last pick is a bit more speculative than some of the others on the list, as it isn't quite profitable yet. But it's growing at a fast clip and is going after a market niche - medical devices for children - that has historically had great economics.OrthoPediatrics (NASDAQ:KIDS) offers a two-dozen product line that covers trauma and deformity, scoliosis, and sports medicine related issues for children. Shares have already tripled since the 2017 initial public offering, and it's not hard to see why. The company has been delivering steady 25%+ annual revenue growth, and they recently turned positive on an EBITDA basis, though they are still reporting EPS losses.With a medical device company like this, however, so much of the cost base is in marketing and overhead. Oftentimes, these companies will sell for huge multiples to larger medical device companies. Those companies can, in turn, immediately earn huge synergies. They do this by cutting duplicate costs and distributing the products through their far larger distribution channels. * 7 Failing Tech Stocks to Disconnect From Now As long as OrthoPediatrics continues putting up strong revenue growth and scoring FDA approval for new products, as it did on multiple occasions in 2019, the stock price should continue to soar. Empire State Realty (ESRT)Source: Shutterstock.com Saving the biggest of the small companies for last, we have one of the world's largest buildings. That's right. Did you know you could own a piece of the Empire State Building? The Empire State Realty Trust (NYSE:ESRT) owns the Empire State Building along with a portfolio of other office buildings in the New York City metro area.Shares have dropped from $20 to $14 in recent years. This has been for several reasons. For one, there's currently a weak office market in New York City. The "retail apocalypse" has also caused more storefront vacancies in Manhattan, where Empire State has a large presence; its buildings have retail on the ground level. Finally, the trade war - and now coronavirus - are lowering the inflow of tourists to New York. Those are tourists, who, in turn, drop tons of money at the Empire State Building Observatory and related attractions.That Observatory is a key element of the bull thesis. Its revenues have been growing for 10% a year over the past two decades. That's even despite the 9/11 attacks, the Financial Crisis, and other setbacks. With the rise of Instagram (NASDAQ:FB) culture and experiences, top-notch tourist attractions like the Empire State Building are one-of-a-kind properties and will enjoy rising values in coming years as investors seek to find trophy assets. With shares down 30% in recent years, this apple is ripe for the picking.Ian Bezek has written more than 1,000 articles for InvestorPlace.com and Seeking Alpha. He also worked as a Junior Analyst for Kerrisdale Capital, a $300 million New York City-based hedge fund. You can reach him on Twitter at @irbezek. At the time of this writing, he owned CTT, ESRT, NYCB, GWRS, and FB stock. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Failing Tech Stocks to Disconnect From Now * 5 Ideal Dividend Stocks for New Investors * 4 Stocks to Buy No Matter Who Wins the 2020 Election The post 7 Small Cap Stocks That Pack a Wallop appeared first on InvestorPlace.
OrthoPediatrics Corp. (“OrthoPediatrics”) (KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that the Company is scheduled to release its fourth quarter and full year 2019 financial results on Wednesday, March 4, 2020, after the market closes. OrthoPediatrics will host a conference call on Thursday, March 5, 2020, at 8:00 a.m. ET to discuss the results. The dial-in numbers are (855) 289-4603 for domestic callers and (614) 999-9389 for international callers.
WARSAW, Ind., Jan. 13, 2020 -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today.
OrthoPediatrics Corp. (“OrthoPediatrics”) (KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that it has completed the sale of substantially all of the assets related to the adult product offering of Vilex in Tennessee, Inc. (“Vilex Adult Business”) to Vilex LLC (“Buyer”), an affiliate of Squadron Capital LLC (“Squadron Capital”). In addition, Buyer was granted a license to manufacture and sell products utilizing the external fixation technology developed by Orthex, LLC, an affiliate of OrthoPediatrics, subject to certain restrictions in favor of OrthoPediatrics on sales to certain pediatric accounts.
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the third quarter. You can find articles about an individual hedge fund's trades on numerous financial […]